Philip Morris
Passive Smoking and Passive Thinking
Fields
- Author
- Kawachi, I.
- Pearce, N.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Site
- R529
- Named Organization
- New Zealand Medical Journal
- Author (Organization)
- New Zealand Medical Journal
- Wellington School of Medicine
- Named Person
- Hirayama
- Lee
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- gic02a00
Document Images
8' NOVEMBER 1989 NEW ZEALAND MEDICAL J©URNAL f a'7- `57-> 593
r >
to c~
Correspondence
Letters to the editor should be siQned by all authors, typ.wrttten in double spacinp, and not exc..d
!00 words of~taxt excluding
ref.renc.s. References should be in the 1laneouver style. Over-lona letters may be shorten.d wfthout
refer.nce to the auttwrs
unleas it is apecifically stated' that thhr may not.
Passive smokinp and passive thinkin
rises to unacceptable levels not only implies an arguable value
judgment on their part but is illogical and t supported by any
evidence that I know, thougb it has to acknowledged as a
possibility. No trial has ahowa that def treatment confers
benef5t tnone has been designed' t~o d sol. and although left
v6mtricvlar bypertropby an regresa .vi aome forms of trastmenI
(generally:,tbe ezpensive onea!I there evidence that permanent
ultraatructitral changes occur in the yocirdlum. Common sense
suggests that trxtment should staeced as soon as a proper
diagnosis aecordiag to current 'delines is made.
I noted the subtk chaage ia ideatity of the decision maker
from the doctor to tbe patiea tbe caae o! my hypothetical 30
year old. This raises in sting questions. Whose is the
responsibility if the patie t makes the wrong decision?' ls it
nalistie to expect him to view his deasion at regular intervals.
and if so. on what gro ds will be neverse it? Will'this happen
before or after tbe t of hemiplegia or dyspnoea'.',
TDe drug aide eff are important for the patient and as s
determinant of the eraII ratio of costs to benefits. I believe the
point I was mak4ia clear enough and''I' leave it to practitioners
to decide from t,lieu experience whether side effects such as
impotence are le4ersibk on srithdrawal'of the offending agent or
E o,
q
Mr Lee's objeetion to the evidkaee on passive smoking (NZ Med
~ L J 1989: 102: 5391 hingea on his theory that miaclaaaifiution of
~ g t a proportion of smokers as nonsmokers might explria the
observed associ.tion between passive smoking and lung caacer.
~ C However his own book on the subject It{, which he cited. is itself
a 100-page monument to bias. In it, be makes an exhaustive
exploration of the possibility that smokers are miar3asaified as
nonsmokers, while completely ignoring the fact that' the smoking
habits of the spouse are equally likely to be miicllusified, thus
biasing the relative risk estimate towards 1.0. Given the
widespread exposure to passive smoking in society. it ia likely
that epidetttiologic studies so far have underestimated the
megnitude of risk.
J udgtng by his remarks on Hirayami s study 1YL. Mr Lx does
not appear to have realised that the age and occupation-
standardised rate ratios for ischaemic heart disease have been
reported' for 117 year follow up 12I The age and occupation-
standardised figures were similar to the rate ratios standardised
for age only 121. We have a complimentary copy of this paper
available should Mr Lee wish to read' it.
As witti Mr Lee. the views we express ars always our own,
However, we do not receive any tees when we express them.
Perhaps this helps dkrify the issue of miscJkssification, which is
really verrv straightforward. and almost invariably l.ads to an
underestimation of the passive smoking effect.
lchiro Kawachi. Department of Community Health.
Neil Pearce;, Welliagtan School of Medicine.
Wellington.
I I.w P\ M~.clusil~cawenol ae.okae6 l.GU and puuw.sn,olun6Arerr.of Ne
..gsenc- ln~awn.l ArcWve" of Qnvp.uaWand H..IdA, Suppement. Hrddbrrir
Spr»rer S'er1.6..198f
2 H u..am. 7 l.unf euutr m JLpan eM.cu of eumum..nd.n po.Nw noekeg In Mu.tl
A1 [one.Peoi1.~nR c.neer caura snd yrev.os.mm he. YorkVri.6 C6kmr
1 eirrn. uonal 19F.. 17695
Treatment of hypertension
Kawachi and Purdie s neply lNZ Med J 1989: 102: 5401 to my letter
I1I raises important issues in the debste about the benefits of'
treating hypertension. Two main points require serious
consideration. The first is contained in the advice that I should
consult their data pertaining to treatment at a blood' ressure
greater than 100 mmHg 121, and to accept that ~ex dau
represent the expected gain with treatment if h rtension is
treated according to the recently published gui lioes.,This is
wrong. The advice fails to recognise that e definition of
hypertension by trial~ protocols is quite erent from that
suggested by recent guidelines. and it is not cult to show that
trial patients are unrepresentative of th A.ger population and
are at lower risk even at equal~levelry o~' lood pressure because
of e:clusion criteria and the method o lection. A patient whose
diastolic blood'pressure is 100 afta several readings taken
over a reasonable time interval ' t higher risk than if select.ed'
from a low risk populatio on the basis of screening
measurements. In the place treaaed group of the MRC trial.
whose records I am t1y studying, the unadjusted
cardiovascular event rate t entry for those with diastolic blood
pressure greater than I mmHg an-30221 was 8.1v1000?yr. but
in those with the s blood pressure 3 months into the trial
/n-1198i~ lequivaJent to a definition of hypertension more in
keeping with the,,giiidelinesl the corresponding figure was 10.3
l.%lillar and Levkr. unpublishedl: This illustrates that current
guidelines havE the effect of identifying a subset of patients with
a greater risfr. thereby optimising the efficiency of treatment
measured as the number of patients treated per event avoided.
in this case 373 versus 116 respectively. These figures are much
lower than those presented by Kawaehi and Pludie 121.
The second point relates to the long term benefits of treatment..
This is a complex and important issue which cannot be fully
addressed here. Suffice to say that Kawachi and Purdie's
' suggestion that treacment can be deferred until the blood pressure
not.
A previous-'paper from my cornespondents' department has
compared IudfavourablyJ the cost of treating hypertension with
cardiac traAsplantatron Isl. and the ciear implication from their
publicatiqLs is that they regard the treatment of' mild
hypertension as prohibitively eapensive., We have agreed with
their canclusion. up to a point µ.5{.! but have provided cost benefit
analyses baaed on both trials of treatment and current
management guidelines. It would be instructive to see similar
calculations from Kawachi and Purdie.
JI A Millar. MRC Blood Pressure Uhit.
4t-'estern lnfirmarv.
Glasgow - G11 BNT.
Scotland. UK.
I Mill4 JA.'Rvtnrat e(.hyprtr.aarYm A2M.d J 1999 )0Y47e2K...du I. Pu+dx G SSr b.e.lru aed n.k. of
u+at.n6 mald u om.rav hYp-so KZM.d'J 1969. 102 3714
Naieoim L. J~duoo R. K..aW l. Sae~u R 1. tJr PAarvi.edoneal vutm.m ol ~m~k
3
bocdnrr hyprt.n.ao aaa'.H.cuw m NaYr pwmyn4ae` 12M.d J 196F101 i 16' 71
4 Mill.r JA. H.nro PC.'tnr.emmin ot uosuo6 mdd nyp.rten.ao !:ZM.d
J1.i6l. 70) T75
S 1[illi.r JA. Han.mPC. E~ to.u.ud'bn.fiu of u..ws6 aWd hvpen.o.m. rrqWu
frm . vo.. r.cuoe.) moS.l TZ M.EJIY66..J01 623'5
Diet and behaviour
I write in response to the leading artick.. Diet an ' ehaviour (NZ
Med J 1989: 102: 499u l am the mother of t eliildren as well
as being a general practitioner. Chtr 3+.o- year d daughter is food
sensitive. and I have no doubt that the gestion of food's or
additives that, dis.gt~e .vith her esux eunaratiag behaviour..
dark aii des under her eyes. night +v g f 1.30 am-4.30 am); loss
of appetite. intrtasaf' thirst. vul tis and joint p.ins. These
reactions have been confirmed several occasions by Ioften
inadvertenti challenge tests. ave been manipulating her diet
for a year with excellent res s and improved sleep. and contest
that. far from a nega ~ e effect, ir has develbped great
responsibility and con in her S year old'sisur that she should
not be ezposed to C s that make her ill.
Critical observa ' n iias long been the backbone of medical
practice. Accura deductions have been made before the process
in question w derstood: We need' look no further than the
develbpment' vaceination by Edward Jenner. the correlation
between h dwashing and puerperal infection noted by lgnaz
Semmdw ss and the discovery of penicillul by Ale=ander
Ffemin
Parehts and teachen are ttie, people best able to assess the
behaviour of children. Early and subtle beliaviour changes ve
urtlllcely to be noticed by independent researchers who do oot
kdow the children. We also are not aware of the cumulative effect
pf these small behavioural ehaages on the .ducational life of t:be
